BioSpace Movers & Shakers, Nov. 6
The Pharma Data
NOVEMBER 5, 2020
has been appointed to the additional role of president and will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Before GSK, Rosén was senior vice president, U.S. from 1993 to 1995.
40 
Let's personalize your content